ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSpese di vendita, generali e amministrative251.25 M247.78 M259.79 M265.09 M275.68 M1.05 BRicerca e sviluppo57.73 M59.06 M61.9 M63.41 M66.83 M251.21 MReddito operativo261.69 M316.53 M373.05 M354.85 M315.61 M1.36 BProventi non operativi, Totale——————Oneri finanziari, al netto degli interessi capitalizzati7.5 M7.67 M11.32 M10.65 M9.21 M38.85 MProventi non operativi, esclusi gli oneri finanziari——————Entrate/uscite straordinarie——————Utile al lordo delle imposte256.39 M310.08 M362.35 M344.77 M306.98 M1.32 BQuota di utile——————Imposte40.24 M67.41 M68.36 M70.16 M58.79 M264.73 MInteressi di minoranza——————Altri proventi/oneri al netto delle imposte——————Utile netto al lordo delle attività cessate216.15 M242.68 M293.99 M274.61 M248.19 M1.06 BAttività cessate——————Utile netto216.15 M242.68 M293.99 M274.61 M248.19 M1.06 BRegolazione della diluizione——————Dividendi privilegiati——————Utile netto diluito attribuibile agli azionisti ordinari216.15 M242.68 M293.99 M274.61 M248.19 M1.06 BUtile base per azione (EPS base)2.642.983.663.433.113.17Utile diluito per azione (EPS diluito)2.622.963.633.43.0913.08Numero medio di azioni ordinarie in circolazione82.47 M81.32 M80.41 M80.1 M80.43 M322.25 MAzioni diluite in circolazione83.25 M81.92 M80.99 M80.67 M81.03 M324.62 MEBITDA291.82 M347.71 M405.88 M388.24 M349.43 M1.49 BEBIT258.11 M313.64 M370.11 M351.61 M310.7 M1.35 BCosto del fatturato385.42 M375.05 M416.19 M423.5 M434.92 M1.65 BAltri costi del venduto——————Ammortamento e svalutazione (liquidità)33.71 M34.06 M35.77 M36.63 M38.72 M145.18 M
IDEXX Laboratories Inc
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.